Mauro Ciro, Chianese Salvatore, Cocchia Rosangela, Arcopinto Michele, Auciello Stefania, Capone Valentina, Carafa Mariano, Carbone Andreina, Caruso Giuseppe, Castaldo Rossana, Citro Rodolfo, Crisci Giulia, D'Andrea Antonello, D'Assante Roberta, D'Avino Maria, Ferrara Francesco, Frangiosa Antonio, Galzerano Domenico, Maffei Vincenzo, Marra Alberto Maria, Mehta Rahul M, Mehta Rajendra H, Paladino Fiorella, Ranieri Brigida, Franzese Monica, Limongelli Giuseppe, Rega Salvatore, Romano Luigia, Salzano Andrea, Sepe Chiara, Vriz Olga, Izzo Raffaele, Cademartiri Filippo, Cittadini Antonio, Bossone Eduardo
Cardiology Division, A. Cardarelli Hospital, Via Cardarelli, 9, 80131 Naples, Italy.
Department of Advanced Biomedical Sciences, University of Naples Federico II, Via Sergio Pansini, 5, 80131 Naples, Italy.
J Clin Med. 2023 Jan 20;12(3):846. doi: 10.3390/jcm12030846.
Acute heart failure (AHF) is the most frequent cause of unplanned hospital admission in patients of >65 years of age and it is associated with significantly increased morbidity, mortality, and healthcare costs. Different AHF classification criteria have been proposed, mainly reflecting the clinical heterogeneity of the syndrome. Regardless of the underlying mechanism, peripheral and/or pulmonary congestion is present in the vast majority of cases. Furthermore, a marked reduction in cardiac output with peripheral hypoperfusion may occur in most severe cases. Diagnosis is made on the basis of signs and symptoms, laboratory, and non-invasive tests. After exclusion of reversible causes, AHF therapeutic interventions mainly consist of intravenous (IV) diuretics and/or vasodilators, tailored according to the initial hemodynamic status with the addition of inotropes/vasopressors and mechanical circulatory support if needed. The aim of this review is to discuss current concepts on the diagnosis and management of AHF in order to guide daily clinical practice and to underline the unmet needs. Preventive strategies are also discussed.
急性心力衰竭(AHF)是65岁以上患者非计划住院的最常见原因,并且与发病率、死亡率和医疗费用的显著增加相关。已经提出了不同的AHF分类标准,主要反映了该综合征的临床异质性。无论潜在机制如何,绝大多数病例都存在外周和/或肺充血。此外,在最严重的病例中可能会出现心输出量显著降低并伴有外周灌注不足。诊断基于体征和症状、实验室检查以及非侵入性检查。排除可逆性病因后,AHF的治疗干预主要包括静脉注射(IV)利尿剂和/或血管扩张剂,根据初始血流动力学状态进行调整,必要时添加正性肌力药物/血管升压药以及机械循环支持。本综述的目的是讨论AHF诊断和管理的当前概念,以指导日常临床实践并强调未满足的需求。还讨论了预防策略。